C07D 241/08
With oxygen atoms directly attached to ring carbon atoms
Official title: with oxygen atoms directly attached to ring carbon atoms
C07D241/08 (With oxygen atoms directly attached to ring carbon atoms) appears on 612 US grants and 568 published applications in this corpus.
Search patents in C07D- Granted patents
- 612
- Published applications
- 568
- Assignees
- 313
- Inventors
- 1,830
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 4 | 0 |
| 1978 | 5 | 0 |
| 1979 | 5 | 0 |
| 1980 | 7 | 0 |
| 1981 | 10 | 0 |
| 1982 | 4 | 0 |
| 1983 | 4 | 0 |
| 1984 | 13 | 0 |
| 1985 | 11 | 0 |
| 1986 | 6 | 0 |
| 1987 | 19 | 0 |
| 1988 | 7 | 0 |
| 1989 | 13 | 0 |
| 1990 | 5 | 0 |
| 1991 | 5 | 0 |
| 1992 | 4 | 0 |
| 1993 | 7 | 0 |
| 1994 | 6 | 0 |
| 1995 | 5 | 0 |
| 1996 | 2 | 0 |
| 1997 | 17 | 0 |
| 1998 | 7 | 0 |
| 1999 | 15 | 0 |
| 2000 | 8 | 0 |
| 2001 | 14 | 2 |
| 2002 | 18 | 21 |
| 2003 | 12 | 27 |
| 2004 | 8 | 28 |
| 2005 | 14 | 27 |
| 2006 | 15 | 20 |
| 2007 | 10 | 15 |
| 2008 | 10 | 16 |
| 2009 | 18 | 34 |
| 2010 | 25 | 35 |
| 2011 | 14 | 24 |
| 2012 | 26 | 29 |
| 2013 | 23 | 32 |
| 2014 | 27 | 24 |
| 2015 | 27 | 23 |
| 2016 | 15 | 27 |
| 2017 | 21 | 22 |
| 2018 | 13 | 19 |
| 2019 | 12 | 15 |
| 2020 | 24 | 25 |
| 2021 | 13 | 21 |
| 2022 | 20 | 17 |
| 2023 | 10 | 25 |
| 2024 | 11 | 16 |
| 2025 | 7 | 18 |
| 2026 | 10 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as Nav1.8 inhibitors1 Sep 2026US 12,723,035 B2Merck Sharp & Dohme Corp.
- Process for the diastereomerically pure preparation of DL/LD-methionylmethionine25 Aug 2026US 12,715,848 B2Evonik Operations GmbH
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Sirtuin modulating compounds, including sirtuin activating compounds, and applications thereof23 Apr 2026US 2026/0109713 A1
- Nitrosation Reagents and Methods9 Apr 2026US 2026/0098021 A1
- Urease inhibiting composition and use of same19 Mar 2026US 2026/0078068 A1Fertinagro Biotech, S.L.
- Piperazine compounds19 Mar 2026US 2026/0078097 A1Spark Therapeutics, Inc.
- Sulfur-containing Compounds and Compositions Thereof for Delivery of Nucleic Acids12 Feb 2026US 2026/0042732 A1Poseida Therapeutics, Inc.
Most cited
By later US patents
- Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors218US 5,861,510 APfizer Inc. · 1999
- Arylsulfonylamino hydroxamic acid derivatives213US 5,863,949 APfizer Inc. · 1999
- Inhibitors of farnesyl-protein transferase204US 5,856,326 AMerck & Co., Inc. · 1999
- Immunoregulatory diketopiperazine compounds150US 4,289,759 AOrtho Pharmaceutical Corporation · 1981
- Piperazine diones148US 3,976,773 AJohn Wyeth & Brother Limited · 1976